Every material Form 8-K HYDROFARM HOLDINGS GROUP, INC. has filed with the SEC since October 09, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Hydrofarm sold about 8.6 million common shares and pre-funded warrants at $0.905 per share in a registered direct and private placement, with gross proceeds of $8.3 million before fees and expenses. Investors also received common warrants for up to 9,210,975 shares at $0.78, which dilutes existing holders and adds potential future share issuance. The filing also describes side letter and registration terms with lenders tied to a restructuring, including rights to designate board members subject to stockholder approval.
Registered direct offering of 1,599,400 shares at $0.905 per share, plus a concurrent private placement of 6,971,575 shares and pre-funded warrants for 640,000 shares, all closed October 27, 2026.
Common warrants for up to 9,210,975 shares at $0.78 per share expire 5.5 years after issue; the placement agent, ThinkEquity LLC, receives a cash fee of 8% of the purchase price.
Under a side letter with lenders, the lenders may designate 1 initial director and up to 3 additional directors, subject to stockholder approval under Nasdaq Rule 5635.
The company must file a resale registration statement by the 15th calendar day after the registration rights agreement date, or pay partial liquidated damages of 2.0% of the subscription amount for each affected holder.
Hydrofarm priced a registered direct offering and concurrent private placement with expected gross proceeds of about $8.3 million, and agreed to satisfy its $109 million senior secured term loan in full by issuing 27.5 million shares of Series 1 Non-Voting Convertible Preferred Stock and warrants for 27.5 million common shares. The conversion and warrant exercise require stockholder approval, and the filing lists dilution to existing stockholders as a risk.
Offering priced at $0.905 per share; expected gross proceeds of about $8.3 million before placement agent fee and expenses, with closing expected on or about October 27, 2026
Term loan of $109 million to be satisfied in full through 27.5 million Series 1 Non-Voting Convertible Preferred Stock shares and Lender Warrants for 27.5 million common shares at $0.78 exercise price
Concurrent private placement includes 9,210,975 Common Warrants exercisable at $0.78 and expiring five and a half years from issuance
Conversion and warrant exercise are subject to shareholder approval; the filing also cites risk of failing to regain Nasdaq continued listing compliance
On October 5, 2026, Hydrofarm entered into a mutual release agreement settling all claims related to an engagement between the parties. As part of the deal, the company agreed, subject to certain milestones, to issue 300,000 non-voting convertible preferred shares, which would convert into 300,000 shares of common stock once stockholders approve the issuance as required by Nasdaq rules. The filing also furnishes an investor presentation posted October 7, 2026, but gives no financial results.
Agreement and mutual release dated October 5, 2026 settles all claims related to the parties' engagement
Company agreed to issue 300,000 non-voting convertible preferred shares, subject to certain milestones
Preferred shares convert into 300,000 common shares only after stockholder approval under Nasdaq rules
Investor presentation posted October 7, 2026 and furnished as Exhibit 99.1
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every HYDROFARM HOLDINGS GROUP, INC. filing is on SEC EDGAR ↗. 8-K briefs of other companies →